BioPharma Resources

Drugs by condition

Drugs approved for enlarged prostate (bph)

Brand-name prescription drugs and biologics whose FDA label lists enlarged prostate (bph) as an approved use. Matched on the label phrases: "benign prostatic hyperplasia".

Last checked: Nov 19, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations

Brand-name drugs approved

7

Still marketed, NDA or BLA

Drug classes

4

Novel drugs

5

New molecular entities and new biologics

In development

1

Investigational drugs in Phase 2 or 3

Newest approvals

The most recently first-approved brand-name drugs for enlarged prostate (bph).

  • Gemtesa (Vibegron) · Sumitomo Pharma Am NovelDec 23, 2020
  • Jalyn (Dutasteride, Tamsulosin Hydrochloride) · Waylis Therap Jun 14, 2010
  • Cardura Xl (Doxazosin Mesylate) · Viatris Feb 22, 2005
  • Cialis (Tadalafil) · Lilly NovelOrphanNov 21, 2003
  • Uroxatral (Alfuzosin Hydrochloride) · Advanz Pharma NovelJun 12, 2003

All approved drugs for enlarged prostate (bph), by class

Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 73 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.

5-alpha Reductase Inhibitor (2)

  • Proscar Finasteride · Organon · 1992
  • Jalyn Dutasteride, Tamsulosin Hydrochloride · Waylis Therap · 2010

beta3-Adrenergic Agonist (1)

  • Gemtesa Vibegron · Sumitomo Pharma Am · 2020

Phosphodiesterase 5 Inhibitor (1)

  • Cialis Tadalafil · Lilly · 2003

Class not listed in FDA's data (3)

  • Uroxatral Alfuzosin Hydrochloride · Advanz Pharma · 2003
  • Cardura Doxazosin Mesylate · Viatris · 1990
  • Cardura Xl Doxazosin Mesylate · Viatris · 2005

Drugs in development for enlarged prostate (bph)

Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.

Search the pipeline
  • N0728Phase 31 trial

    Eurofarma Laboratorios S.A. · Benign Prostatic Hyperplasia With Lower Urinary Tract Symptoms

1 discontinued brand-name drugs whose label still names it

More on enlarged prostate (bph): recruiting trials · published research

Related in kidney and urology: Chronic kidney disease · IgA nephropathy · Overactive bladder · Erectile dysfunction

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.